Browsing by Author "Schumann, Anika"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
- ItemRole of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer(London : BioMed Central, 2010) Cadenas, Cristina; Franckenstein, Dennis; Schmidt, Marcus; Gehrmann, Mathias; Hermes, Matthias; Geppert, Bettina; Schormann, Wiebke; Maccoux, Lindsey J.; Schug, Markus; Schumann, Anika; Wilhelm, Christian; Freis, Evgenia; Ickstadt, Katja; Rahnenführer, Jörg; Baumbach, Jörg I.; Sickmann, Albert; Hengstler, Jan G.Introduction: The purpose of this work was to study the prognostic influence in breast cancer of thioredoxin reductase 1 (TXNRD1) and thioredoxin interacting protein (TXNIP), key players in oxidative stress control that are currently evaluated as possible therapeutic targets. Methods: Analysis of the association of TXNRD1 and TXNIP RNA expression with the metastasis-free interval (MFI) was performed in 788 patients with node-negative breast cancer, consisting of three individual cohorts (Mainz, Rotterdam and Transbig). Correlation with metagenes and conventional clinical parameters (age, pT stage, grading, hormone and ERBB2 status) was explored. MCF-7 cells with a doxycycline-inducible expression of an oncogenic ERBB2 were used to investigate the influence of ERBB2 on TXNRD1 and TXNIP transcription. Results: TXNRD1 was associated with worse MFI in the combined cohort (hazard ratio = 1.955; P < 0.001) as well as in all three individual cohorts. In contrast, TXNIP was associated with better prognosis (hazard ratio = 0.642; P < 0.001) and similar results were obtained in all three subcohorts. Interestingly, patients with ERBB2-status-positive tumors expressed higher levels of TXNRD1. Induction of ERBB2 in MCF-7 cells caused not only an immediate increase in TXNRD1 but also a strong decrease in TXNIP. A subsequent upregulation of TXNIP as cells undergo senescence was accompanied by a strong increase in levels of reactive oxygen species. Conclusions: TXNRD1 and TXNIP are associated with prognosis in breast cancer, and ERBB2 seems to be one of the factors shifting balances of both factors of the redox control system in a prognostic unfavorable manner.